MCYSX Performance — NYLI Candriam Emerging Markets Equity Fund, Class R6
Data updated: 2026-09-23
MCYSX returned +21.76% year to date and +44.23% over one year to Jul 2026. Annualised returns are +21.68% over 3 years and +6.15% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $180, against $164 for the category, and to $144 over one year, against $134. Volatility over the past three years was 18.11% a year. In the 12 months to Jul 2026 the fund lost a net $21.4M, and assets reached $124.81M.
MCYSX Growth of $100
What $100 invested in NYLI Candriam Emerging Markets Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | MCYSX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $144 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $180 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $135 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $207 | $188 |
MCYSX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +21.76% |
| 1 year | +44.23% |
| 3 years (annualised) | +21.68% |
| 5 years (annualised) | +6.15% |
MCYSX Annual Returns
Calendar-year total returns of NYLI Candriam Emerging Markets Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +21.76% |
| 2025 | +35.71% |
| 2024 | +12.37% |
| 2023 | +7.43% |
| 2022 | −28.02% |
| 2021 | −3.73% |
| 2020 | +36.43% |
| 2019 (Aug–Dec) | +9.77% |
MCYSX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +11.3% | +4.7% | −9.6% | +15.8% | +7.7% | −0.5% | −6.8% | — | — | — | — | — |
| 2025 | +1.3% | −0.7% | +0.2% | +0.3% | +3.9% | +8.0% | +1.1% | +4.3% | +8.8% | +3.7% | −2.4% | +3.1% |
| 2024 | −4.5% | +6.1% | +2.8% | +0.6% | +1.8% | +4.4% | −1.2% | +1.1% | +6.0% | −2.9% | −2.2% | +0.3% |
| 2023 | +9.2% | −7.5% | +3.5% | −2.4% | −1.7% | +4.0% | +6.1% | −5.5% | −3.5% | −3.9% | +7.8% | +2.7% |
| 2022 | −2.0% | −4.3% | −1.4% | −8.3% | +0.7% | −7.4% | −1.9% | −1.1% | −10.6% | −1.1% | +10.6% | −4.2% |
| 2021 | +3.4% | +1.2% | −2.6% | +3.5% | +0.8% | +2.1% | −5.5% | +1.6% | −5.6% | +1.7% | −5.0% | +1.3% |
| 2020 | −3.7% | −3.2% | −14.9% | +11.7% | +3.2% | +8.8% | +10.5% | +2.9% | −2.4% | +3.0% | +9.7% | +9.4% |
| 2019 | — | — | — | — | — | — | — | −2.1% | +1.1% | +3.7% | −0.7% | +7.7% |
MCYSX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 18.11%
- 3-year Sharpe ratio: 0.95 (vs 4.5% risk-free rate)
- Best month: +15.77% (Apr 2026)
- Worst month: −9.63% (Mar 2026)
MCYSX Fund Flows
Monthly money in and out of NYLI Candriam Emerging Markets Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$21.4M
- 12-month gross sales (incl. reinvestments): $39.7M
- Sales ÷ redemptions: 0.65×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.4M | $1.4M | −$36K |
| Jun 2026 | $4.2M | $4.2M | −$5K |
| May 2026 | $2.6M | $7.9M | −$5.3M |
| Apr 2026 | $3.5M | $5.1M | −$1.6M |
| Mar 2026 | $5.8M | $4.4M | $1.4M |
| Feb 2026 | $3.0M | $5.0M | −$2.0M |
| Jan 2026 | $2.7M | $3.3M | −$625K |
| Dec 2025 | $8.2M | $1.8M | $6.4M |
| Nov 2025 | $2.2M | $12.2M | −$10.0M |
| Oct 2025 | $2.5M | $10.2M | −$7.8M |
| Sep 2025 | $1.2M | $861K | $298K |
| Aug 2025 | $2.5M | $4.6M | −$2.1M |
MCYSX Assets Under Management
Net assets of NYLI Candriam Emerging Markets Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $124.81M |
| 2026-04-30 | $130.09M |
| 2026-01-31 | $120.79M |
| 2025-10-31 | $118.15M |
| 2025-07-31 | $108.94M |
| 2025-04-30 | $100.14M |
| 2025-01-31 | $110.78M |
| 2024-10-31 | $123.23M |
| 2024-07-31 | $157.95M |
| 2024-04-30 | $161.46M |
| 2024-01-31 | $146.65M |
| 2023-10-31 | $152.02M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.